Carregant...
Development of a high-throughput solubility screening assay for use in antibody discovery
Poor solubility is a common challenge encountered during the development of high concentration monoclonal antibody (mAb) formulations, but there are currently no methods that can provide predictive information on high-concentration behavior of mAbs in early discovery. We explored the utility of meth...
Guardat en:
| Publicat a: | MAbs |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6601704/ https://ncbi.nlm.nih.gov/pubmed/30913963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2019.1589851 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|